Medi-Caps

Medi-Caps Financial Leverage

The Financial Leverage (Equity Multiplier) of Medi-Caps (523144.BO) as of Oct 16, 2026 is 1.03. In the previous year, Financial Leverage (Equity Multiplier) was 1.03 — a change of 0.03% (higher).

Financial Leverage

1.03

YoY

0.03%

Last updated:

Financial Leverage (Equity Multiplier) of Medi-Caps is 2026 1.03 . Financial Leverage (Equity Multiplier) of Medi-Caps was 2025 1.03 . It decreases by 0.03% higher compared to the previous year.

The Medi-Caps Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2019
1.12 INR
Jan 1, 2020
1.05 INR
Jan 1, 2021
1.10 INR
Jan 1, 2022
1.12 INR
Jan 1, 2023
1.06 INR
Jan 1, 2024
1.05 INR
Jan 1, 2025
1.03 INR
Jan 1, 2026
1.03 INR
The Medi-Caps Financial Leverage history
YEARFinancial LeverageYoY
1.03+0.03%
1.03-1.70%
1.05-0.98%
1.06-5.24%
1.12+2.25%
1.10+4.75%
1.05-6.13%
1.12-0.30%
1.12+2.33%
1.09-3.34%
1.13+3.16%
1.10-10.26%
1.22—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medi-Caps Stock analysis

What does Medi-Caps do? Medi-Caps Ltd is a company listed on the Bombay Stock Exchange with the ticker 523144.BO and ISIN INE442D01010. Headquartered in Indore, India, the company operates within the Materials sector, specifically in the Packaging industry. Its IPO was held on January 11, 1990. The company's official website is https://medicaps.com/. According to the provided source description, Medi-Caps Ltd is involved in manufacturing and marketing pharmaceutical products. The source also mentions that the company is engaged in the real estate business and has a subsidiary named Medgel Private Limited. However, the source is treated as untrusted, so these details are not confirmed. The company's primary focus as per the given information is in the packaging sector, and it is based in Indore, Madhya Pradesh. The company's operations and business activities are defined by its sector and industry classification, with no additional details on product names, founding year, or specific financial figures provided beyond the IPO date. The website serves as the official online presence for the company. The company's structure includes a subsidiary, Medgel Private Limited, though the nature of this subsidiary's operations is not specified. The source description's claims about pharmaceuticals and real estate are noted but not verified as part of the factual profile. Medi-Caps is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medi-Caps stock

Financial Leverage (Equity Multiplier) of Medi-Caps is 1.03 in 2026.

Financial Leverage (Equity Multiplier) of Medi-Caps changed from 1.03 to 1.03, representing a 0.03% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Medi-Caps since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Medi-Caps with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Medi-Caps

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Medi-Caps